3 Diagnostic Lab, Surface Treatment and Rice Exporter Stocks With a Strong Future Roadmap: Suraksha Diagnostic, Grauer & Weil (India) and LT Foods
- October 15, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Suraksha Diagnostic Rs 318.30, P/E 46.05. Grauer & Weil Rs 81.06, P/E 22.12. LT Foods Rs 418.05, P/E 21.98. Closing prices of 14 Oct 2026.
Quick Answer
Diagnostic lab, surface treatment and rice exporter stocks with the clearest long-term roadmaps today include Suraksha Diagnostic in diagnostic and pathology testing through a network of labs and collection centres, Grauer & Weil in surface treatment chemicals and related industrial products and LT Foods in basmati rice and packaged foods sold under brands such as Daawat. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 5.1% at Grauer & Weil and 25.7% at LT Foods. P/E stands at 46.05 for Suraksha Diagnostic (industry 62.79), 22.12 for Grauer & Weil (industry 36.60) and 21.98 for LT Foods (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Diagnostic lab, surface treatment and rice exporter stocks give investors exposure to health testing, industrial chemicals and food staples sold at home and abroad. Volumes, pricing and input costs decide how much of that demand turns into profit.
Readers comparing diagnostic lab, surface treatment and rice exporter stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.
This list covers three diagnostic lab, surface treatment and rice exporter stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, Grauer & Weil (India) for surface treatment chemicals and related industrial products and LT Foods for basmati rice and packaged foods sold under brands such as Daawat. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Diagnostic Lab, Surface Treatment and Rice Exporter Stocks?
Diagnostic lab, surface treatment and rice exporter stocks are shares of companies that run diagnostics, make chemicals or sell packaged food. Results depend on volumes, pricing and input costs, so margins and cash flow separate the stronger names.
Diagnostic Lab, Surface Treatment and Rice Exporter Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three diagnostic lab, surface treatment and rice exporter stocks as of the 14 Oct 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| Suraksha Diagnostic | 318.30 | 1,614 | 46.05 | 62.79 | 13.15% | 0.53 |
| Grauer & Weil (India) | 81.06 | 3,540 | 22.12 | 36.60 | 15.16% | 0.01 |
| LT Foods | 418.05 | 14,072 | 21.98 | 34.85 | 13.83% | 0.36 |
Among healthcare and chemicals stocks, all three trade at a discount to their industry P/E multiples.
Why Do Diagnostic Lab, Surface Treatment and Rice Exporter Stocks Have a Strong Roadmap in India?
Diagnostic lab, surface treatment and rice exporter stocks have a strong roadmap in India because rising health checks, industrial output and global appetite for basmati keep adding volumes for these firms. Three drivers stand out.
- Preventive health: More people test early and often.
- Industrial output: Factories use surface treatment chemicals regularly.
- Rice exports: Global buyers prefer basmati varieties.
Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline
Suraksha Diagnostic’s roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.
Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.
Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P/E of 46.05 against an industry P/E of 62.79, the stock trades below its industry multiple.
What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.
Grauer & Weil (India): Surface Treatment Chemicals Drive the Pipeline
Grauer & Weil’s roadmap rests on surface treatment chemicals and related industrial products, with several business lines supporting earnings.
Revenue grew from Rs 782.11 crore in FY22 to Rs 1,239.78 crore in FY26, a 58.5% rise, and FY26 revenue was 5.1% higher than FY25. FY26 net profit rose 4.3% to Rs 164.03 crore. Over four years, net profit rose from Rs 78.77 crore in FY22 to Rs 164.03 crore. In Q1 FY27, revenue grew 17.0% to Rs 311.11 crore. Operating margin was 18.87% in FY26.
Debt to equity is 0.01 and return on equity is 15.16%. FY26 operating cash flow was Rs 151.86 crore against capital expenditure of Rs 53.65 crore. Grauer & Weil paid a dividend of Rs 1 per share for FY26, a yield of 1.28%. At a P/E of 22.12 against an industry P/E of 36.60, the stock trades below its industry multiple.
What to watch: The P/E of 22.12 against an industry P/E of 36.60 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
LT Foods: Basmati and Packaged Foods Anchor the Roadmap
LT Foods’ roadmap rests on basmati rice and packaged foods sold under brands such as Daawat, with exports and branded sales supporting revenue.
Revenue grew from Rs 5,450.58 crore in FY22 to Rs 11,023.06 crore in FY26, a 102.2% rise, and FY26 revenue was 25.7% higher than FY25. FY26 net profit rose 2.2% to Rs 625.38 crore. Over four years, net profit rose from Rs 309.20 crore in FY22 to Rs 625.38 crore. In Q1 FY27, revenue grew 26.4% to Rs 3,161.29 crore, and net profit rose 8.9% to Rs 183.45 crore. Operating margin was 11.35% in FY26.
Debt to equity is 0.36 and return on equity is 13.83%. FY26 operating cash flow was Rs 910.50 crore against capital expenditure of Rs 359.62 crore. LT Foods paid a dividend of Rs 3 per share for FY26, a yield of 0.74%. At a P/E of 21.98 against an industry P/E of 34.85, the stock trades below its industry multiple.
What to watch: The P/E of 21.98 against an industry P/E of 34.85 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Best Diagnostic Lab, Surface Treatment and Rice Exporter Stocks in India: Suraksha Diagnostic vs Grauer & Weil vs LT Foods on Key Financials
Among the best diagnostic lab, surface treatment and rice exporter stocks in India, Suraksha Diagnostic leads on FY26 operating margin; Grauer & Weil leads on FY26 net profit growth and return on equity; LT Foods leads on FY26 revenue growth and Q1 FY27 revenue growth. The table puts the numbers side by side.
| Metric | Suraksha Diagnostic | Grauer & Weil | LT Foods |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 313.58 | 1,239.78 | 11,023.06 |
| FY26 revenue growth | 22.5% | 5.1% | 25.7% |
| FY26 net profit (Rs Cr) | 31.40 | 164.03 | 625.38 |
| FY26 net profit growth | 1.4% | 4.3% | 2.2% |
| FY26 operating profit margin | 32.01% | 18.87% | 11.35% |
| Q1 FY27 revenue growth (YoY) | 20.7% | 17.0% | 26.4% |
| Return on equity | 13.15% | 15.16% | 13.83% |
| P/E ratio | 46.05 | 22.12 | 21.98 |
| Debt to equity | 0.53 | 0.01 | 0.36 |
| Dividend yield | 0.02% | 1.28% | 0.74% |
| FY26 operating cash flow (Rs Cr) | 81.83 | 151.86 | 910.50 |
Healthcare, chemicals and food earnings follow volumes, pricing and input costs, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Diagnostic Lab, Surface Treatment and Rice Exporter Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen diagnostic lab, surface treatment and rice exporter stocks and shortlist diagnostic lab, surface treatment and rice exporter stocks to buy.
- Compare each stock’s P/E with its industry P/E, which differs by company here.
- Check operating margin, debt and cash flow together.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Risks to Consider Before Investing in Diagnostic Lab, Surface Treatment and Rice Exporter Stocks
- Input costs: Changes in raw material prices can affect margins.
- Seasonal demand: Weather and crop cycles can shift sales between quarters.
- Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.
Download the Univest iOS App or Univest Android App to track Suraksha Diagnostic, Grauer & Weil and LT Foods live.
Final Take: Which Stock Has the Strongest Roadmap?
These three healthcare and chemicals stocks cover diagnostics, surface treatment chemicals and basmati rice. Suraksha Diagnostic leads on FY26 operating margin; Grauer & Weil leads on FY26 net profit growth and return on equity; LT Foods leads on FY26 revenue growth and Q1 FY27 revenue growth.
Across diagnostic lab, surface treatment and rice exporter stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the diagnostic lab, surface treatment and rice exporter stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Diagnostic Lab, Surface Treatment and Rice Exporter Stocks
Which are the best diagnostic lab, surface treatment and rice exporter stocks in India with a strong roadmap?
Ans. Suraksha Diagnostic, Grauer & Weil (India) and LT Foods stand out for their roadmaps in diagnostics, surface treatment chemicals and basmati rice. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 5.1% at Grauer & Weil and 25.7% at LT Foods, and return on equity ranges from 13.15% to 15.16%.
Is Suraksha Diagnostic a good stock to buy now?
Ans. Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P/E of 46.05 against an industry P/E of 62.79. Valuation, input costs and seasonal demand move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Suraksha Diagnostic, Grauer & Weil and LT Foods?
Ans. The P/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 22.12 for Grauer & Weil (industry 36.60) and 21.98 for LT Foods (industry 34.85). All of them trade below the industry multiple.
Which of these diagnostic lab, surface treatment and rice exporter stocks has the highest return on equity?
Ans. Grauer & Weil (India) has the highest return on equity at 15.16%, followed by LT Foods at 13.83% and Suraksha Diagnostic at 13.15%.
What are the risks of investing in diagnostic lab, surface treatment and rice exporter stocks?
Ans. The main risks are input costs, seasonal demand and quarterly trends. Changes in raw material prices can affect margins.
How did Suraksha Diagnostic, Grauer & Weil and LT Foods perform in Q1 FY27?
Ans. Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Grauer & Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. LT Foods reported revenue of Rs 3,161.29 crore, up 26.4% year on year, and net profit rose 8.9% to Rs 183.45 crore.
Do diagnostic lab, surface treatment and rice exporter stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 1.28% for Grauer & Weil and 0.74% for LT Foods, based on dividends declared for FY26.
How can I invest in diagnostic lab, surface treatment and rice exporter stocks in India?
Ans. You can buy diagnostic lab, surface treatment and rice exporter stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.
